MDXG

SEC source: 0001376339-22-000038 · wf-form4_164979866808881.xml · nonDerivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · President, Regenerative Med.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,605

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3.

SEC source: 0001376339-22-000026 · wf-form4_164694778126649.xml · nonDerivative · entry 1

Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,431

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000025 · wf-form4_164694771945794.xml · nonDerivative · entry 1

Kashyap Rohit · CIK 0001435655 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,844

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000027 · wf-form4_164694786510802.xml · nonDerivative · entry 1

WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,220,645

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000024 · wf-form4_164694765756055.xml · nonDerivative · entry 1

Graves Mark · CIK 0001803893 · SVP & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,014

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000023 · wf-form4_164694760057391.xml · nonDerivative · entry 1

Carlson Peter M · CIK 0001379320 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,698

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000022 · wf-form4_164694741185779.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,345

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000021 · wf-form4_164694725686210.xml · nonDerivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · EVP, Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,034

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000020 · wf-form4_164694718293968.xml · nonDerivative · entry 1

Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,360

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001376339-22-000009 · wf-form4_164616879224210.xml · nonDerivative · entry 1

Carlson Peter M · CIK 0001379320 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,441

F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.81 to $4.87, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001803893-22-000002 · wf-form4_164608351760940.xml · nonDerivative · entry 1

Graves Mark · CIK 0001803893 · SVP & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,248

F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001761796-22-000002 · wf-form4_164582689062570.xml · nonDerivative · entry 1

Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,586

F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.50 to $4.51, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001288245-22-000002 · wf-form4_164582706702923.xml · nonDerivative · entry 1

WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,266,256

F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.26 to $4.455, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001796044-22-000002 · wf-form4_164582667565948.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,335

F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

SEC source: 0001376339-21-000097 · wf-form4_162923376480953.xml · nonDerivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · EVP, Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,706

F1 · kind: Represents shares sold to pay associated taxes upon vesting.

SEC source: 0001379320-21-000006 · wf-form4_162767551630263.xml · nonDerivative · entry 2

Carlson Peter M · CIK 0001379320 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 410,841

F2 · shares: Represents shares withheld to pay associated taxes upon vesting.

SEC source: 0001379320-21-000006 · wf-form4_162767551630263.xml · nonDerivative · entry 1

Carlson Peter M · CIK 0001379320 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424,115

F1 · shares: Represents satisfaction of performance criterion with respect to previously-granted performance-vested restricted stock units.

SEC source: 0001376339-21-000089 · wf-form4_162756349008710.xml · nonDerivative · entry 1

Graves Mark · CIK 0001803893 · SVP & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,265

F1 · kind: Represents shares withheld to pay associated taxes upon vesting of previously-granted award.

SEC source: 0001288245-21-000006 · wf-form4_162326935875542.xml · nonDerivative · entry 1

WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,327,256

F1 · shares: Reflects sale of shares to cover tax withholding obligation upon vesting of previously-granted award.

F2 · price: The 101,957 shares were sold through separate trades, with the sale prices ranging from $10.45 to $11.05, and a weighted average sale price of $10.685. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate purchase price.

SEC source: 0001376339-21-000077 · wf-form4_162222667862680.xml · nonDerivative · entry 1

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,674

F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-21-000079 · wf-form4_162222708227992.xml · nonDerivative · entry 1

Newton Todd · CIK 0001460878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,427

F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001444810-21-000002 · wf-form4_162222691787921.xml · nonDerivative · entry 1

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,579

F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001834000-21-000002 · wf-form4_162222652822100.xml · nonDerivative · entry 1

Giuliani Michael J · CIK 0001834000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,579

F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-21-000075 · wf-form4_162222636414395.xml · nonDerivative · entry 1

GARDNER PHYLLIS · CIK 0001238646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,479

F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-21-000073 · wf-form4_162222625342159.xml · nonDerivative · entry 1

BEHRENS M KATHLEEN · CIK 0001211701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,427

F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-21-000071 · wf-form4_162222615454628.xml · nonDerivative · entry 1

BIERMAN JAMES L · CIK 0001189534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,427

F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001811814-21-000004 · wf-form4_162007402129472.xml · nonDerivative · entry 1

Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,154

F1 · kind: This transaction represents the netting of shares to pay applicable withholding upon vesting of previously-granted award.

SEC source: 0001376339-21-000034 · wf-form4_161972821997477.xml · nonDerivative · entry 2

GARDNER PHYLLIS · CIK 0001238646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,423

F2 · kind: Grant of restricted stock units which vest in full on the first anniversary date of the grant.

SEC source: 0001376339-21-000034 · wf-form4_161972821997477.xml · nonDerivative · entry 1

GARDNER PHYLLIS · CIK 0001238646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,339

F1 · kind: Grant of restricted stock units which vest in equal parts over three years from the date of the grant.

SEC source: 0001761796-21-000008 · wf-form4_161955548285835.xml · nonDerivative · entry 1

Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,324

F1 · kind: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

SEC source: 0001803893-21-000010 · wf-form4_161955566527739.xml · nonDerivative · entry 1

Graves Mark · CIK 0001803893 · SVP & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,770

F1 · kind: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock.

SEC source: 0001761796-21-000006 · wf-form4_161523874777070.xml · nonDerivative · entry 1

Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,548

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001435655-21-000002 · wf-form4_161523845494404.xml · nonDerivative · entry 1

Kashyap Rohit · CIK 0001435655 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,614

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001803893-21-000008 · wf-form4_161524072791147.xml · nonDerivative · entry 1

Graves Mark · CIK 0001803893 · SVP & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,237

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001811814-21-000002 · wf-form4_161523863814370.xml · nonDerivative · entry 1

Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,587

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001796044-21-000004 · wf-form4_161523834719598.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,835

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001376339-21-000006 · wf-form4_161523822300592.xml · nonDerivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · EVP, Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,068

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001379320-21-000004 · wf-form4_161523812702406.xml · nonDerivative · entry 1

Carlson Peter M · CIK 0001379320 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 388,903

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001288245-21-000004 · wf-form4_161523785733506.xml · nonDerivative · entry 1

WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,429,213

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001761796-21-000004 · wf-form4_161410927689618.xml · nonDerivative · entry 1

Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,827

F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

SEC source: 0001761796-21-000002 · wf-form4_161402250386074.xml · nonDerivative · entry 1

Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,399

F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

SEC source: 0001796044-21-000002 · wf-form4_161402422041612.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,531

F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

SEC source: 0001379320-21-000002 · wf-form4_161402374087589.xml · nonDerivative · entry 1

Carlson Peter M · CIK 0001379320 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,668

F1 · acquired: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

SEC source: 0001803893-21-000002 · wf-form4_161402331234720.xml · nonDerivative · entry 1

Graves Mark · CIK 0001803893 · SVP & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,929

F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

SEC source: 0001288245-21-000002 · wf-form4_161402220618839.xml · nonDerivative · entry 1

WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,094,060

F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock.

SEC source: 0001376339-20-000155 · wf-form4_160829554252868.xml · nonDerivative · entry 1

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,618

F1 · shares: Represents grant of restricted stock that vess in equal parts on July 21, 2021; July 21, 2022; and July 21, 2023.

SEC source: 0001376339-20-000157 · wf-form4_160829579403043.xml · nonDerivative · entry 2

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,523

F2 · shares: Grant of restricted stock which vests in full on the earlier of one year from the grant date or on the date of the Company's next Annual Shareholders Meeting.

SEC source: 0001376339-20-000157 · wf-form4_160829579403043.xml · nonDerivative · entry 1

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,349

F1 · shares: Grant of restricted stock which vests in equal parts over three years from the date of the grant.

SEC source: 0001376339-20-000156 · wf-form4_160829571147895.xml · nonDerivative · entry 2

Giuliani Michael J · CIK 0001834000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,523

F2 · shares: Grant of restricted stock which vests in full on the earlier of one year from the grant date or on the date of the Company's next Annual Shareholders Meeting.

SEC source: 0001376339-20-000156 · wf-form4_160829571147895.xml · nonDerivative · entry 1

Giuliani Michael J · CIK 0001834000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,349

F1 · shares: Grant of restricted stock which vests in equal parts over three years from the date of the grant.